NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-19-277 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications for cancer epidemiologic research. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as improving data collection methods, developing and validating methods of exposures and biological effects, such as epigenetics and metabolomics, and their application in population-based research, functional assessment of genetic variants, and assessing recruitment methods for understudied populations.
Notice NOT-CA-19-051 from the NIH Guide for Grants and Contracts
Notice NOT-CA-19-050 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-274 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Funding Opportunity PAR-19-275 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Funding Opportunity PAR-19-276 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Notice NOT-DA-19-040 from the NIH Guide for Grants and Contracts
Notice NOT-HL-19-701 from the NIH Guide for Grants and Contracts
Notice NOT-MD-19-023 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-278 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.
Funding Opportunity RFA-DA-20-012 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for commercializable, blockchain-based products that aim to improve the inefficient processes currently in existence within the SUD healthcare ecosystem.
Funding Opportunity RFA-DA-20-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for commercializable, blockchain-based products that aim to improve the inefficient processes currently in existence within the SUD healthcare ecosystem
Notice NOT-DA-19-034 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-GM-19-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the NIGMS Human Genetic Cell Repository (HGCR). The repository will maintain the current collection of cell cultures and DNA samples and will acquire, characterize, and expand high-quality cell samples, and distribute cell lines and DNA isolated from them to qualified biomedical researchers.
Notice NOT-AT-19-024 from the NIH Guide for Grants and Contracts
Notice NOT-AT-19-026 from the NIH Guide for Grants and Contracts
Notice NOT-NS-19-062 from the NIH Guide for Grants and Contracts
Notice NOT-NS-19-065 from the NIH Guide for Grants and Contracts
Notice NOT-NS-19-061 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-105 from the NIH Guide for Grants and Contracts